Severe thrombocytopenia without major haemorrhage in dengue in a patient on dual antiplatelet therapy; a real world clinical experience

View at publisher Summarise with VIRAT
Authors: A. T. Matthias, Viduni Suraweera
Cited by: 0
References: 2

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Dengue is endemic in tropical regions and bleeding, ranging from minor to life-threatening, is a dreaded complication. With the increasing incidence of atherosclerotic cardiovascular disease in low- to middle-income countries where Dengue is prevalent, whether to stop or continue antiplatelet agents in patients with thrombocytopenia is a clinical conundrum.

Fields of Study & Subjects

Mosquito-borne diseases and control Platelet Disorders and Treatments Antiplatelet Therapy and Cardiovascular Diseases

Publication details

Journal / source
Tropical Doctor
Volume
56
Issue
3
Pages
577–578
Publication date
23 March 2026
Language
EN